#CTAD2025 wrapped: Despite trial setbacks, incredible energy around diversity, data sharing & diagnostics. Our AI Prize semifinals showcased outstanding collaboration—5 finalists heading to Copenhagen!
@shelbynewsad Under Obama, we always went in … but you couldn’t order supplies or visit the supply stores in building 10. Cores were closed too. Plus, you’re technically trespassing if you’re not an essential employee.
So excited about our strategic partnership with @ubiquigent to combine our AI drug discovery platform RubDUB 🐤 with their deep expertise in deubiquitinating enzymes.
https://t.co/WL6vnx0680
Philadelphia is purple this week in honor of the researchers, clinicians & dementia professionals from all over the world gathered here for #AAIC24 to advance dementia science and clinical practice. 🔔💜 #ENDALZ
🎥: @discoverPHL & Nathaniel Bayona
We’re grateful to work with rising stars in #ADRD research. Thanks to the Gates Sr. AD Fellows who joined us at #AAIC24. We’re inspired by their commitment to collaboration and innovation in ADRD research.
Learn more about the fellows here: https://t.co/PWvUOXjZVM
Communication Game is a great illustration of experimental biology.
Person A builds a little construction with a handful of LEGO bricks. They then describe it to Person B, who tries to reproduce it based purely on the description.
Person A does not see what Person B’s making.
Thank you to our partners who are making breakthroughs in #ADRD through collaboration across the globe. We’re excited to gather at #AAIC24 and continue accelerating progress toward new diagnostics, treatments, and cures together.
When we see the #lecanemab and #donanemab data for what it shows rather than for what we want to see, there is no net benefit for patients with #Alzheimers. The risks of brain edema, hemorrhage, and accelerated brain atrophy are high.
https://t.co/WhUxsOvpHE